NCT01551563

Stavanger University Hospital Inflammatory Bowel Disease Trial

Management of Inflammatory Bowel Disease in the Stavanger Area - a Prospective Evaluation of Standardized Treatment Regimens on Disease Outcome With Focus on Mucosal Healing and Associations to Fatigue

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 700 (estimated)
• Sponsor: Helse Stavanger HF · Other Government
• Sex: All
• Age: 16 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The study aims at studying the outcomes of a protocol-based handling of newly diagnosed Inflammatory bowel disease ( IBD ) patients within a defined uptake area in Norway. It is a descriptive study and no hypothesis is predefined. Cytokine studies, QoL and fatigue assessment will be included for hypothesis-generating purposes.

Detailed description

none considered needed

Conditions

• IBD

Timeline

• Start date: 2012-04-01
• Primary completion: 2026-12-01
• Completion: 2030-12-01
• First posted: 2012-03-12
• Last updated: 2025-05-16

Locations

1 site across 1 country: Norway